Cited by 185Autism Spectrum Disorder ResearchNeuroendocrine regulation and behaviorGenetics and Neurodevelopmental Disorders

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism

Open access

Parker, Karen J., Oztan, Ozge, Libove, Robin A., Mohsin, Noreen, Karhson, Debra S., Sumiyoshi, Raena D., Summers, Jacqueline E., Hinman, Kyle E., Motonaga, Kara S., Phillips, Jennifer M., Carson, Dean S., Fung, Lawrence K., Garner, Joseph P., Hardan, Antonio Y.·2019·Science Translational Medicine

DOI 10.1126/scitranslmed.aau7356PMC PMC6716148

Open this paper in CoChat — free account

Abstract

Intranasal delivery of the neuropeptide vasopressin improves social abilities in children with autism spectrum disorder.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.aau7356

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384
Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders
Lord, C., Rutter, M., & Le Couteur, A. (1994) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02172145 · Cited by 9,065
Untitled work
(1976) · Medical Entomology and Zoology · Cited by 8,899
The NimStim set of facial expressions: Judgments from untrained research participants.
Tottenham, N., Tanaka, J. W., Leon, A. C., McCarry, T., Nurse, M., Hare, T. A., Marcus, D. J., Westerlund, A., Casey, B., & Nelson, C. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.05.006 · Cited by 3,454
Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012
Christensen, D. L., Baio, J., Braun, K. V. N., Bilder, D., Charles, J., Constantino, J. N., Daniels, J., Durkin, M. S., Fitzgerald, R. T., Kurzius-Spencer, M., et al. (2016) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6503a1 · Cited by 1,964
ECDEU Assessment Manual: (591322011-001)
Guy, W. (1976) · PsycEXTRA Dataset · doi:10.1037/e591322011-001 · Cited by 1,896
Validation of a Brief Quantitative Measure of Autistic Traits: Comparison of the Social Responsiveness Scale with the Autism Diagnostic Interview-Revised
Constantino, J. N., Davis, S. A., Todd, R. D., Schindler, M. K., Gross, M. M., Brophy, S. L., Metzger, L. M., Shoushtari, C. S., Splinter, R., & Reich, W. (2003) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1025014929212 · Cited by 1,611
Anxiety in children and adolescents with autism spectrum disorders
White, S. W., Oswald, D., Ollendick, T., & Scahill, L. (2009) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.01.003 · Cited by 1,427 · cited 1×
“Anxiety was selected as an outcome measure due to its frequent comorbidity with ASD (67) and the existence of literature linking AVP to anxiety (42).”
Background
Sniffing neuropeptides: A transnasal approach to the human brain
Born, J., Lange, T., Kern, W., McGregor, G. P., Bickel, U., & Fehm, H. L. (2002) · Nature Neuroscience · doi:10.1038/nn0602-849 · Cited by 1,356

Flagged first, then by citations

Show all 68 references

Research works printed but not linked: 5

C. Lord M. Rutter P. C. DiLavore S. Risi K. Gotham S. L. Bishop R. J. Luyster W. Guthrie Autism Diagnostic Observation Schedule Second Edition (ADOS-2) Manual (part 1): Modules 1–4 (Western Psychological Services 2012).
G. H. Roid Stanford Binet's Intelligence Scales Fifth Edition Technical Manual (Riverside Publishing 2003).
R. Mead The Design of Experiments: Statistical Principles for Practical Applications (Cambridge Univ. Press 1988).
J. Neter M. H. Kutner C. Nachtscheim W. Wasserman Applied Linear Statistical Models (McGraw-Hill ed. 4 1996).
A. Grafen R. Hails Modern Statistics for the Life Sciences (Oxford Univ. Press 2002) pp. XV 351.

Sorted by citations

Items 101–185 of 185

Modulating reward and aversion: Insights into addiction from the paraventricular nucleus
Huang, S., Shi, C., Tao, D., Yang, C., & Luo, Y. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70046 · Cited by 6
The social salience network hypothesis of autism: Disrupted network activity, oxytocin signaling, and implications for social symptoms
Patwardhan, A., & Choe, K. Y. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102787 · Cited by 7
A Pro-social Pill? The Potential of Pharmacological Treatments to Improve Social Outcomes After Pediatric Traumatic Brain Injury
Semple, B. D., & Raghupathi, R. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.714253 · Cited by 5
Utility of Downstream Biomarkers to Assess and Optimize Intranasal Delivery of Oxytocin
DuBois, M. C., Tseng, A., Francis, S. M., Haynos, A. F., Peterson, C. B., & Jacob, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061178 · Cited by 5
Vasopressin deficiency: a hypothesized driver of both social impairment and fluid imbalance in autism spectrum disorder
Clarke, L., Gesundheit, N., Sherr, E. H., Hardan, A. Y., & Parker, K. J. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02497-6 · Cited by 5
Self-citation
Tinkering with the vasopressin pathway in autism
d’Arc, B. F., Mottron, L., Elsabbagh, M., & Jacquemont, S. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aax7315 · Cited by 5
Bioavailability and pharmacokinetic profile of balovaptan, a selective, brain-penetrant vasopressin 1a receptor antagonist, in healthy volunteers
Derks, M., Lennon-Chrimes, S., Guenther, A., Squassante, L., Wandel, C., Szczesny, P. J., Paehler, A., & Kletzl, H. (2021) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2021.1948009 · Cited by 5
History, pharmacology and therapeutic mechanisms of 3,4‐methylenedioxymethamphetamine (MDMA)
Casey, A. B., & Heifets, B. D. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70225 · Cited by 4
Zebrafish Bioassay for Screening Therapeutic Candidates Based on Melanotrophic Activity
Hong, T. I., Hwang, K.-S., Choi, T., Kleinau, G., Scheerer, P., Bang, J. K., Jung, S.-H., & Kim, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179313 · Cited by 4
Natura Non Facit Saltus: The Adaptive Significance of Arginine Vasopressin in Human Affect, Cognition, and Behavior
Crespi, B. J., Procyshyn, T. L., & Mökkönen, M. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.814230 · Cited by 3
Chronic Adaptations in the Dorsal Horn Following a Cervical Spinal Cord Injury in Primates
Fisher, K. M., Garner, J. P., & Darian‐Smith, C. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0877-23.2023 · Cited by 3
Self-citation
Endocrine circuitry in autism spectrum disorders: A systematic review of mechanistic insights and clinical implications
Angelopoulou, M., Siaperas, P., Livadas, S., Karantana, E., Papadimitriou, D. T., & Angelopoulos, N. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.09.009 · Cited by 4
Nose to Brain Targeted Drug Therapy: A Review
Vani, D. M., Ezhilarasi, A. S., & Saju, S. (2020) · Saudi Journal of Medical and Pharmaceutical Sciences · doi:10.36348/sjmps.2020.v06i11.002 · Cited by 3
Maternal Thyroid Supplementation Prevents Autistic-relevant Social Behavior and Hypothalamic Oxytocin Depletion Produced by Developmental Exposure to Environmental ToxicantsPreprint
Kozlova, E. V., Denys, M. E., Bishay, A. E., Luna, C. N., Angelis, M. D., Campoy, L., Habbal, A., Lam, A. A., Luvsanravdan, N., Colton, A. G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.28.667293 · Cited by 2
Sex difference in the effects of ventral pallidum vasopressin 1a receptor partial knockdown on social behavior in mice
Friesen, C. N., Hartswick, D., Selke, A., Vries, G. J. D., & Petrulis, A. (2025) · Hormones and Behavior · doi:10.1016/j.yhbeh.2025.105792 · Cited by 3
Three‐dimensional quantification of oxytocin neurons in the hypothalamic paraventricular nucleus reveals sex‐ and subregion‐specific differences in two genetic mouse models of autism
Patwardhan, A., Li, S., Chen, J. A., & Choe, K. Y. (2025) · Journal of Neuroendocrinology · doi:10.1111/jne.70092 · Cited by 2
Intranasal vasopressin, but not oxytocin, decreases ethanol intake in socially housed mice
Nipper, M. A., Zweig, J. A., Johnson, M., Abshire, K. M., & Ryabinin, A. E. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06962-0 · Cited by 2
Cerebrospinal Fluid Vasopressin Concentration Is a Biomarker of Autistic Social Impairment and Hypothalamic Vasopressin Gene Expression in Humans
Oztan, O., Zhu, C., Nguyen, D. K. K., West, R. B., Garner, J. P., & Parker, K. J. (2026) · Autism Research · doi:10.1002/aur.70181 · Cited by 2
Self-citation
Neuropeptidergic systems in psychiatric disorders
Hodzic, S., & Riedemann, T. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1654292 · Cited by 2
A brain circuit of bidirectional modulation of social and nonsocial cognition by androgens and estrogens in male mice
Aspesi, D., Varatharajah, A., Cioffi, L., Diviccaro, S., Caruso, D., Becke, N., Lalonde, J., Perreault, M. L., Melcangi, R. C., MacLusky, N. J., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2600302123 · Cited by 2
Effects of Arginine Vasopressin on Hippocampal Myelination in an Autism Rat Model: A RNA-seq and Mendelian Randomization Analysis
Bao, X., Zhou, B., & Wen, M. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2911394 · Cited by 2
Development of precision medicine approaches to advance clinical trials for autism and social behavior: A research imperative
Boulton, K., & Guastella, A. J. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2424066122 · Cited by 3
Simultaneous, real-time tracking of many neuromodulatory signals with multiplexed optical recording of sensors on a micro-endoscope
Kalugin, P. N., Soden, P. A., Massengill, C. I., Amsalem, O., Porniece, M., Stolberg, Z. B., Guarino, D. C., Tingley, D., Zhang, S. X., Benson, J. C., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.07.008 · Cited by 2
Transition-Age Youth with Autism Spectrum Disorder
Gwynette, M., Marrus, N., & Vasa, R. (2021) · Springer eBooks · doi:10.1007/978-3-030-62113-1_11 · Cited by 1
Autism Spectrum Disorder
Harris, J. C., & Coyle, J. T. (2024) · Oxford University Press eBooks · doi:10.1093/med/9780199928118.003.0016 · Cited by 2
Control of Social Withdrawal of Mice Deficient for the Autism Gene Magel2 by Restoration of Vasopressin-Oxytocin Dialogue in SeptumPreprint
Borie, A. M., Dromard, Y., Dufner, D., Pollozi, E., Huzard, D., Tömböli, C., Olma, A., Manning, M., Colson, P. H., Guillon, G., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/800425 · Cited by 2
The salience of competing nonsocial objects reduces gaze toward social stimuli, but not the eyes, more in typically developing than autistic boys
Cai, X., Le, J., Shou, X., Wuyun, G., Wang, X., Han, S., Han, J., Kendrick, K. M., & Zhang, R. (2022) · Autism Research · doi:10.1002/aur.2714 · Cited by 1
The Vasopressin V1A Receptor and Aggression
Tan, O., & Bowen, M. T. (2023) · Springer eBooks · doi:10.1007/978-3-030-98711-4_90-1 · Cited by 2
Synthesis and Study of Effects of the Arginine-Vasopressin Fragment (6-9) Analog on Rat Behavior in the “Social Behavior” Experiment
Baradzina, K. U., Стаханова, А. А., Kviatkouskaya, L. I., Мартинович, В. П., Voskresenskaya, O. G., & Gribovskaya, О. V. (2025) · Neurochemical Journal · doi:10.1134/s1819712425700734 · Cited by 1
Novel therapeutics in autism spectrum disorder
Kevelson, S. D., Elmaghraby, R., Patel, F., Brown, H. R., Gorenstein, M., Bain, J., Grinspan, Z. M., Pedapati, E. V., Veenstra-VanderWeele, J. M., & Vandana, P. (2026) · Neurotherapeutics · doi:10.1016/j.neurot.2026.e00857 · Cited by 5
The Value of Non-Domination in Supported Decision-Making for Research Participation for Individuals with Intellectual and Developmental Disabilities
Howard, D., & McCarthy, A. M. (2026) · The Journal of Law Medicine & Ethics · doi:10.1017/jme.2025.10193 · Cited by 1
Arginine-vasopressin systems in autistic phenotype schizophrenia: effect of a genetic variant of AVPR1a and AVPR1b
Yamasaki, F., Nakata, Y., Kanahara, N., Miyazawa, A., Mashimo, Y., Hirose, Y., Oda, Y., Niitsu, T., Onouchi, Y., & Iyo, M. (2026) · Journal of Neural Transmission · doi:10.1007/s00702-026-03149-5 · Cited by 1
Medical treatment of autism spectrum disorder in children: Current evidence, controversies, and clinical challenges
Elbeltagi, Y. M., Rasool, A. O. A. R. E., Elkashlan, A. M., & Al‐Beltagi, M. (2026) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v15.i2.117274 · Cited by 1
Autism Spectrum Disorder: Integrating Genetic and Environmental Risk
Kamijo, S., Miwa, H., & Ikeda, K. (2026) · Cells · doi:10.3390/cells15110985 · Cited by 2
The Neurotrophic, Neuroprotective, Mitogenic, Antioxidant, and Antiapoptotic Properties of Vasopressin
Belokoskova, S. G., & Tsikunov, S. G. (2023) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-023-01461-1 · Cited by 1
Tales from the life and lab of a female social neuroscientist
Parker, K. J. (2023) · Comprehensive Psychoneuroendocrinology · doi:10.1016/j.cpnec.2023.100202 · Cited by 1
Self-citation
A population pharmacokinetics model of balovaptan to support dose selection in adult and pediatric populations
Stark, F. S., Chavanne, C., Derks, M., Jolling, K., Lagraauw, H. M., Lindbom, L., Prins, N. H., & Baumann, H. E. S. (2024) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-023-09898-0 · Cited by 1
Altered vocal communication in adult vasopressin-deficient Brattleboro rats
Cordes, C. N., Fredricks, C. P., Liu, L., Brakey, D. J., Daniels, D., & Paul, M. J. (2024) · Physiology & Behavior · doi:10.1016/j.physbeh.2024.114699 · Cited by 1
Protein/Peptides Drug Delivery System
Pandey, D., Gupta, N., Yadav, A. K., & Sharma, A. (2024) · Springer eBooks · doi:10.1007/978-981-97-4970-6_7 · Cited by 1
Psychopharmacology in Autism
Zappia, K. J., & Erickson, C. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-78143-8_12 · Cited by 1
Psychopharmacology of Autism Spectrum Disorder
Ozdemir, S., Keary, C. J., Joshi, G., Ceranoglu, A. T., & McDougle, C. J. (2020) · Springer eBooks · doi:10.1007/978-3-030-46295-6_25 · Cited by 1
Applications in medicine: mental health
Janssens, Y., Wynendaele, E., Audenaert, K., & Spiegeleer, B. M. J. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821389-6.00020-0 · Cited by 1
Oxytocin and arginine vasopressin: a bridge between acupuncture and autism spectrum disorder
Zhang, R., Han, J., & Han, S. (2022) · Medical Review · doi:10.1515/mr-2022-0001 · Cited by 1
A novel treatment option for autism spectrum disorder: Vasopressin receptor antagonists
Çöpür, M., & Çöpür, S. (2020) · The Journal of Neurobehavioral Sciences · doi:10.4103/jnbs.jnbs_4_20
Psychopharmacology of autism spectrum disorders and other related comorbidities
Alcera, E. C., Jaehning, M., & Solhkhah, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85031-5.00021-9
La vasopressine
Borie, A. M., Muscatelli, F., Desarménien, M. G., & Jeanneteau, F. D. (2021) · médecine/sciences · doi:10.1051/medsci/2021134
Crossing borders in neurodevelopmental disorders
van Andel, D. M. (2021) · Utrecht University Repository (Utrecht University) · doi:10.33540/943
Gastrointestinal Microbiome: Novel Paradigm Proposed in the Treatment of Autism Spectrum Disorder Associated Social Behavioral Symptoms in Two Rodent ModelsPreprint
Mintál, K., Tóth, A., Hormay, E., Kovács, A., László, K., Bufa, A., Marosvölgyi, T., Kocsis, B., Varga, A., Vizvári, Z., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1235045/v1
An overview of pharmacotherapy in the management of children diagnosed with autism spectrum disorder at a public hospital in KwaZulu-Natal, South AfricaPreprint
Maniram, J., Oosthuizen, F., & Karrim, S. B. (2022) · Research Square · doi:10.21203/rs.3.rs-2182993/v1
Motor Intervention Research Trends for Children with Autism Spectrum Disorder: A Bibliometric Analysis (Preprint)Preprint
Xu, J., Zhou, D., & Xu, F. (2022) · doi:10.2196/preprints.45401
Systematic review of randomized clinical trials testing a pharmacological treatment in adults with autism spectrum disorderPreprint
Miguel, A. P., Moreno, M. L. S. D. O., Peiró, A. M., Gisbert, L., Lugo‐Marín, J., Martínez‐Cayuelas, E., & Ballester, P. (2023) · Research Square · doi:10.21203/rs.3.rs-2759981/v1
Editorial: Neuroendocrine research in health and disease, volume II
Wang, Y., Kendrick, K. M., Chen, X. Q., & Sha, L. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1253725
The Vasopressin V1A Receptor and Aggression
Tan, O., & Bowen, M. T. (2023) · Springer eBooks · doi:10.1007/978-3-031-31547-3_90
Additional file 4 of Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis
Siafis, S., Çıray, O., Wu, H., Schneider‐Thoma, J., Bighelli, I., Krause, M., Rodolico, A., Ceraso, A., Deste, G., Huhn, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19311361
Additional file 7 of Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis
Siafis, S., Çıray, O., Wu, H., Schneider‐Thoma, J., Bighelli, I., Krause, M., Rodolico, A., Ceraso, A., Deste, G., Huhn, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19311373
Differentiated approach to the pharmacotherapy of autism spectrum disorders: biochemical aspects
Бокша, И. С., Prokhorova, T. A., Savushkina, O. K., Терешкина, Е. Б., & Burbaeva, G. S. (2023) · Biochemistry (Moscow) · doi:10.31857/s0320972523030028
TMAO miscompartmentalization is a reversible driver of autism pathophysiologyPreprint
Launay, J., & Vodovar, N. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.30.596635
Chapter 66. Treatment of Autism Spectrum Disorder
Hegarty, J. P., & Hardan, A. Y. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as66
Self-citation
Chapter 2. Neurotransmitters, Receptors, and Transporters
Berg, K. A., Clarke, W. P., Daws, L. C., Frazer, A., Girotti, M., & Lodge, D. J. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as02
Peptides, Proteins and Antibodies
Gennaro, S. I. D., & Lalatsa, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-59478-6_19
Sex Difference in the Effects of Ventral Pallidum Vasopressin 1a Receptor Knockdown on Social Behavior in MicePreprint
Friesen, C. N., Hartswick, D., Selke, A., Vries, G. J. D., & Petrulis, A. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5265287
Neurobiology and behavior associated with early neglect: An exploratory comparison of neglected US children and international adoptees
Spratt, E. G., Brady, K. T., Addo, O. Y., Papa, C. E., Swenson, C. C., Miller, B. S., Contompasis, J. S., & Bellis, M. D. D. (2025) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2025.100155
Autism spectrum disorder and the role of nuclear hormone receptors: insights and therapeutic implications
Chintalapally, S., Rajanala, K., & Upadhyay, A. K. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1655348
Contributions of nonhuman primate research to unraveling the social brain and its impairments
Gacoin, M., Jiang, H., Obliger-Debouche, M., Cléry, J. C., & Sliwa, J. (2025) · Revue de primatologie · doi:10.4000/15cqb · Cited by 1
Additional file 1 of Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis
Siafis, S., Çıray, O., Wu, H., Schneider‐Thoma, J., Bighelli, I., Krause, M., Rodolico, A., Ceraso, A., Deste, G., Huhn, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19311349
Additional file 2 of Genetic and morphological estimates of androgen exposure predict social deficits in multiple neurodevelopmental disorder cohorts
McKenna, B. G., Huang, Y., Vervier, K., Hofammann, D., Cafferata, M., Al-Momani, S. I., Lowenthal, F., Zhang, A., Koh, J.-Y., Thenuwara, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14759823
Additional file 1 of Large multicenter randomized trials in autism: key insights gained from the balovaptan clinical development program
Jacob, S., Anagnostou, E. A., Hollander, E., Jou, R. J., McNamara, N., Sikich, L., Tobe, R. H., Murphy, D., McCracken, J., Ashford, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20056341
Additional file 5 of Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis
Siafis, S., Çıray, O., Wu, H., Schneider‐Thoma, J., Bighelli, I., Krause, M., Rodolico, A., Ceraso, A., Deste, G., Huhn, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19311367
Additional file 6 of Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis
Siafis, S., Çıray, O., Wu, H., Schneider‐Thoma, J., Bighelli, I., Krause, M., Rodolico, A., Ceraso, A., Deste, G., Huhn, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19311370
Additional file 2 of Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis
Siafis, S., Çıray, O., Wu, H., Schneider‐Thoma, J., Bighelli, I., Krause, M., Rodolico, A., Ceraso, A., Deste, G., Huhn, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19311355
Additional file 3 of Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis
Siafis, S., Çıray, O., Wu, H., Schneider‐Thoma, J., Bighelli, I., Krause, M., Rodolico, A., Ceraso, A., Deste, G., Huhn, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19311358
Additional file 2 of The distribution of neuroligin4, an autism-related postsynaptic molecule, in the human brain
Toya, A., Fukada, M., Aoki, E., Matsuki, T., Ueda, M., Eda, S., Hashizume, Y., Iio, A., Masaki, S., & Nakayama, A. (2023) · Figshare · doi:10.6084/m9.figshare.26566856
Additional file 1 of The distribution of neuroligin4, an autism-related postsynaptic molecule, in the human brain
Toya, A., Fukada, M., Aoki, E., Matsuki, T., Ueda, M., Eda, S., Hashizume, Y., Iio, A., Masaki, S., & Nakayama, A. (2023) · Figshare · doi:10.6084/m9.figshare.26566853
Novel targets for autism spectrum disorder: Recent developments, challenges, and future perspectives
Dwivedi, S., Tschang, M., Subburaman, A., Varghese, S., Reddy, S. V., Shukla, S., Pandey, S., Gupta, P., Sharma, P., Kewat, D. P., et al. (2026) · Research in Autism · doi:10.1016/j.reia.2026.202900 · Cited by 1
Polymorphisms in GPCR genes: Their role in schizophrenia, autism diseases and response to antipsychotic treatment — A systematic review
DelaCuesta-Barrutia, J., Peñagarikano, O., Ramos-Miguel, A., & Erdozain, A. M. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111669
Oxytocin, vasopressin, and their crosstalk in sexually-dimorphic psychiatric conditions
Yamasue, H. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106641
Low-dose antipsychotics ameliorate maternal separation-induced ultrasound vocalization deficits in the vasopressin-deficient Brattleboro rat pups
Török, B., Fodor, A., Klausz, B., Varga, J. M., & Zelena, D. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111682
New regulators in oxytocin and vasopressin release : role of the endolysosomal two-pore channels
Martucci, L. L. (2021) · theses.fr (ABES) · doi:10.70675/027d1ae2zd2ebz4677za019ze6ccd94cafe9
Nose-to-Brain Delivery of Biologicals
Torres, J., Correia, A. C., & Silva, A. C. (2025) · Springer handbooks · doi:10.1007/978-3-032-01636-2_8
Circuit logic of oxytocin and vasopressin complementary actions
Jeanneteau, F. D., Chakraborty, P., Petitjean, H., & Charlet, A. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1875731
Peripheral oxytocin but not vasopressin concentrations are associated with language skills in young autistic children
Li, Q., Zhao, W., Xu, D., Le, J., Kou, J., Lan, C., Xu, X., Meng, F., Li, X., Shou, X., et al. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1854532
Arginine-vasopressin in the management of brain disorders: recent advancement and future perspective
Kumar, S., Sanap, S., Vasoya, M., Chormale, J., Pandey, P., Khopade, A. J., Sawant, K. K., & Handa, M. (2026) · iPharma · doi:10.1016/j.iphar.2026.100007
Miscompartmentalization of microbiota-derived TMAO is a reversible driver in autism spectrum disorder
Launay, J., & Vodovar, N. (2026) · iScience · doi:10.1016/j.isci.2026.117276
Maternal willingness to participate in research involving neuroimaging, biological sample collection, and data storage: Towards a Multicentre Neurodevelopmental Research in a low-resource setting
Piersson, A. D., Amartey, C., Quartei, S. T., Dzefi‐Tettey, K., Sefogah, P. E., & Lopez, A. R. (2026) · PLoS ONE · doi:10.1371/journal.pone.0344408
Neural Circuits of Social Behavior in Autism Spectrum Disorder: From Mechanism to Intervention
Sparks, K. C. O., & Pedapati, E. V. (2026) · Biological Psychiatry · doi:10.1016/j.biopsych.2026.10.006

Authors: Parker, K. J., Oztan, O., Libove, R. A., Mohsin, N., Karhson, D. S., Sumiyoshi, R. D., Summers, J. E., Hinman, K. E., Motonaga, K. S., Phillips, J. M., Carson, D. S., Fung, L. K., Garner, J. P., & Hardan, A. Y.
Affiliations: Stanford Medicine (US)
Corresponding author: Parker, Karen J.
ORCID: Parker, Karen J.
Oztan, Ozge
Mohsin, Noreen
Karhson, Debra S.
Sumiyoshi, Raena D.
Summers, Jacqueline E.
Hinman, Kyle E.
Motonaga, Kara S.
Phillips, Jennifer M.
Carson, Dean S.
Fung, Lawrence K.
Garner, Joseph P.
Hardan, Antonio Y.
Venue: Science Translational Medicine
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2019-05-08
Volume: 11
Issue: 491
ISSN: 1946-6234 (ISSN-L)
1946-6242
DOI: 10.1126/scitranslmed.aau7356
PMC: PMC6716148
OpenAlex: W2943453749
Cited by: 185
References: 68
Citations by year: 2026: 22 · 2025: 21 · 2024: 23 · 2023: 29 · 2022: 42 · 2021: 27 · 2020: 14 · 2019: 7
FWCI: 13.08
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Science Translational Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of Mental Health (R21MH100387, T32MH019908, K08MH111750)
Autism Speaks (7895)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R21HD083629, R01HD091972)
Stanford’s Department of Psychiatry (N/A)
The Teresa and Charles Michael Endowed Fund for Autism Research and Education (N/A)
The Child Health Research Institute (N/A)
The Yani Calmidis Memorial Fund for Autism Research (N/A)
Mosbacher Family Fund for Autism Research (N/A)
Bass Society (N/A)
Topics: Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords: autism spectrum disorder, social dysfunction, children, anxiety symptoms, repetitive behavior, treatment tolerability, adverse events
MeSH terms: Autism Spectrum Disorder, Administration, Intranasal, Child, Female, Humans, Male, Pilot Projects, Placebos, Social Behavior, Vasopressins, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks